GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Beverages - Non-Alcoholic » Yakult Honsha Co Ltd (TSE:2267) » Definitions » 3-Year EBITDA Growth Rate

Yakult Honsha Co (TSE:2267) 3-Year EBITDA Growth Rate : 9.40% (As of Dec. 2023)


View and export this data going back to 1980. Start your Free Trial

What is Yakult Honsha Co 3-Year EBITDA Growth Rate?

Yakult Honsha Co's EBITDA per Share for the three months ended in Dec. 2023 was 円86.38.

During the past 12 months, Yakult Honsha Co's average EBITDA Per Share Growth Rate was -2.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Yakult Honsha Co was 17.60% per year. The lowest was -4.50% per year. And the median was 6.00% per year.


Competitive Comparison of Yakult Honsha Co's 3-Year EBITDA Growth Rate

For the Beverages - Non-Alcoholic subindustry, Yakult Honsha Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yakult Honsha Co's 3-Year EBITDA Growth Rate Distribution in the Beverages - Non-Alcoholic Industry

For the Beverages - Non-Alcoholic industry and Consumer Defensive sector, Yakult Honsha Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Yakult Honsha Co's 3-Year EBITDA Growth Rate falls into.



Yakult Honsha Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Yakult Honsha Co  (TSE:2267) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Yakult Honsha Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Yakult Honsha Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Yakult Honsha Co (TSE:2267) Business Description

Traded in Other Exchanges
Address
1-19 Higashi Shimbashi 1-chome, Minato-ku, Tokyo, JPN, 105-0021
Yakult is a pioneer in probiotics, which launched the probiotic drinks Yakult in 1935 after Minoru Shirota's discovery of Lactobacillus casei strain Shirota, a strain of lactic acid bacteria proved to be able to live in intestines, in 1930. It operates in 40 countries across four continents selling mainly the Yakult probiotic drinks. Apart from the retail outlets, the home delivery channel, served by a team of 83,000 Yakult Ladies globally, contributes about 45% of its probiotic drink volume. Overseas markets comprise 40% of group sales and profits. Yakult has built a meaningful presence in populated emerging markets including China, Indonesia, Mexico, and Brazil. It plans to step up expansion in the U.S. It also operates a pharmaceutical business with an emphasis on oncology drugs.

Yakult Honsha Co (TSE:2267) Headlines

No Headlines